Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 122 of 1,261
  1. US 11964985

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  2. US 11965020

    Antigen binding molecule formats

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  3. US 11964008

    Method for inactivating zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  4. US 11964010

    Prefusion coronavirus spike proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  5. US 11963959

    Inhibitors for coronavirus

    The Government of the United States, as represented by the Secretary of the Army · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  6. US 11963981

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  7. US 11963953

    Deuterated compounds for restoring mutant p53 function

    PMV PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  8. US 11963970

    Preparation method of ginseng composition with high ginsenoside bioavailability

    STANDARD FOODS (CHINA) CO., LTD · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  9. US 11964003

    Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    XERIS PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  10. US 11964016

    Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  11. US 11964018

    Therapeutic uses for sodium thiosulfate formulations

    Fennec Pharmaceuticals, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  12. US 11964021

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  13. US 11964025

    Peptide-containing linkers for antibody-drug conjugates

    Mersana Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  14. US 11964047

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  15. US 11965161

    Methods and compositions for sensitization of tumor cells to immune therapy

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  16. US 11964960

    Pyridinone- and pyridazinone-based compounds and uses thereof

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  17. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    The Government of the United States · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  18. US 11964024

    B7H4-targeted antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  19. US 11963945

    Ozonides for treating or preventing virus infections

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  20. US 11963533

    Compositions and methods for treating Liberibacter diseases and other bacterial diseases

    The Regents of the University of California · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  21. US 11964948

    Bifunctional chelators and conjugates

    Actinium Phamaceuticals, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  22. CA 3268414

    MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Apr 18, 2024 · Expires Apr 13, 2044

    granted
  23. WO 2024081718

    ANTAGONISTE DU RÉCEPTEUR CGRP POUR LE TRAITEMENT DE LA MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 18, 2024 · Expires Apr 13, 2044

    granted
  24. US 11957704

    Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.